CS Paper Radar

Synthetic training for long-tail haemorrhagic lesion segmentation in data-scarce settings

Yuan Cao, Sumeet Dash, Antonia Zachariadis, Stefanie Schreiber, Katja Neumann, Jose Bernal

cs.CV ·submitted 2026-10-01 12:12 UTC · v1
published

Abstract

Cerebral microbleeds (CMBs) and cortical superficial siderosis (cSS) are imaging markers of cerebral small vessel disease, but their automated segmentation is limited by the scarcity of positive cases and voxel-level annotations. We propose a synthetic training framework for long-tail haemorrhagic lesion segmentation that requires no real lesion annotations for training and leverages radiological description of the lesions. Starting from anatomical brain parcellations, the framework applies spatial augmentation and voxel resampling, procedurally inserts cSS and CMB labels using clinical priors on lesion location and morphology, and synthesises images through randomised intensity assignment, blurring, and Rician noise simulation. Models were trained on dynamically generated image-label pairs and evaluated against manual delineations in 10 cSS cases and 13 CMB cases. The proposed configurations outperformed classical filter baselines. For cSS, the hypointensity constrained model achieved higher AUPRC and AUROC than the Frangi filter (AUPRC: 0.284 vs 0.083; AUROC: 0.907 vs 0.731). For CMBs, explicit synthesis of blood vessels as lesion mimics improved performance over the classical baseline (AUPRC: 0.538 vs 0.004; AUROC: 0.999 vs 0.968). These results support our proposal as a feasible strategy for data-scarce haemorrhagic lesion segmentation.

Comment
Accepted: MICCAI 2026 SASHIMI workshop

Closest papers

Nearest neighbours by meaning across the whole index.

Synthetic-to-Real Transfer in Cerebral Microbleed Generation and Segmentation

eess.IV ·2026-09-30 ·To-Liang Hsu, Ting-Yu Lai, Ching-Ting Lin, Chun-Hao Huang, Wei-Chun Wang
similarity 0.73
Abstract

The development of automated cerebral microbleed (CMB) detection models is hindered by the low prevalence of CMBs and the high cost of expert annotation. To address this limitation, we developed a synthetic CMB generation pipeline and investigated the effectiveness of synthetic lesions for training deep learning detectors. Models trained solely on synthetic data achieved substantial detection performance, reaching approximately 87% of the lesion sensitivity of their real-trained counterparts. We further investigated the complementary roles of synthetic and real data under different training paradigms, revealing that a significant performance gap remains. Moreover, we found that successful synthetic-to-real transfer is strongly dependent on the downstream detection architecture, providing new insight into both the potential and limitations of synthetic data for CMB detection.

0.19

Native-Space 3D CarveMix for Multi-Site T1w Stroke Segmentation

eess.IV cs.CV ·2026-08-24 ·Dexter Wen Jie Teo, Kumaradevan Punithakumar
published similarity 0.68
Abstract · Accepted at the SWITCH+ Workshop (ISLES 2026 Challenge), MICCAI 2026. Springer LNCS

Segmenting ischemic stroke lesions on T1-weighted (T1w) MRI acquired across different scanners and protocols without intensity standardization is difficult because lesions are subtle and share intensity characteristics with cerebrospinal fluid. Standard deep learning architectures trained across multiple centers plateau around Dice 0.66, with acute lesions ($\le 7$ days post-stroke) performing substantially worse due to severe sample scarcity. We combine a MedNeXt-L ($k=5$) backbone with on-the-fly 3D CarveMix augmentation that pastes real lesion patches into healthy brain regions during training. By generating synthetic lesion placements dynamically within each fold with subject-level split isolation, the model sees more diverse lesion patterns without requiring pre-generated copies on disk. We evaluate on 1,453 native T1w scans from 55 clinical centers in the ISLES 2026 challenge. Our method achieves a mean 5-fold cross-validation Dice of 0.648 at 500 epochs, a +0.018 improvement over the MedNeXt-L backbone at a matched training budget (0.630)

0.31

Generalizable Brain Tumor Segmentation with Self-Training and Tumor-Aware Deformations

cs.CV ·2026-09-02 ·Henrique Zan Grande, Jeovane Honorio Alves, Rayson Laroca, Andre Gustavo Hochuli
publishedcode/data similarity 0.67
Abstract · Accepted for presentation at the 2026 International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI) - BraT…

This work presents an approach to the Generalizability Across Tumors (BraTS-GoAT) task of the BraTS 2026 Challenge, which focuses on robust segmentation of brain tumor sub-regions across a heterogeneous patient population. The proposed method employs the nnU-Net framework with a large residual encoder architecture, integrating a semi-supervised learning technique with pseudo-labels generated from the unlabeled training data and a tumor-aware deformable augmentation that locally deforms the lesion while preserving the surrounding anatomy. We evaluate the individual contributions of each component, as well as their combination, using varying proportions of the most confident pseudo-labeled cases. The submitted configuration for the generalization task achieves Dice and NSD scores of 0.881 and 0.473 for Whole Tumor, 0.817 and 0.490 for Tumor Core, and 0.775 and 0.533 for Enhancing Tumor on the BraTS-GoAT validation set, improving over the labeled-only baselines across all tumor regions and confirming that self-training and the proposed augmentation are complementary. Our source code is publicly available at https://github.com/Henrique-zan/brats-goat-2026/.

0.43

A Dual-Stream Regulated Reconstruction and Segmentation Network with Hierarchical Artifact-Prior Modeling for Ultra-Low-Field Pediatric Neuroimaging

cs.CV ·2026-09-17 ·Bahram Jafrasteh, Leo Milecki, Qingyu Zhao
similarity 0.66
Abstract

Automated quality assessment, enhancement, and segmentation of multiple structures in $0.064\,\mathrm{T}$ ultra-low-field pediatric MRI are limited by a low signal-to-noise ratio, weak anatomical boundaries, and frequent artifacts. We present a unified framework for the LISA 2026 Challenge that performs all three tasks together within one inference pipeline. A network with two coupled streams, built on a 3D U-Net, first reconstructs an enhanced uLF volume and then combines the original and enhanced images for subcortical segmentation. To improve boundary stability, we add an auxiliary class covering brain tissue outside the target structures, derived from whole brain masks. A head conditioned on an artifact graph predicts the seven artifact ratings from reconstruction residuals and frozen segmentation features. We address the scarcity of dense annotations using diffeomorphic registration from atlas to target for label propagation and to regularize anatomical reconstruction. We report validation results across all three tasks.

0.12

MicroBT: Centroid-Guided Synergistic Learning for Multi-Modal Micro Brain Tumor Segmentation and Counting

cs.CV cs.AI ·2026-11-10 ·Zhenye Lou, Qing Xu, Stefanie Thust, Dorothee P. Auer, Zhen Chen +1 more
publishedcode/data similarity 0.65
Abstract · Accepted at the 37th British Machine Vision Conference (BMVC), 2026

Multi-modal brain tumor segmentation is essential for clinical diagnosis, radiotherapy planning, and longitudinal monitoring. While recent studies have achieved remarkable overall segmentation performance, they rely on overlap-based objectives that inherently favor large regions, causing sub-3 mm micro-lesions to be systematically suppressed during training. Moreover, existing pixel-level segmentation frameworks lack explicit instance-level modeling, leading to unreliable lesion counting that directly impacts clinical staging and therapeutic decisions. To address these challenges, we propose MicroBT, a unified multi-modal framework for micro brain tumor segmentation and counting. Our core insight is that a fundamental geometric property is inherently scale-invariant: regardless of size, each lesion possesses a well-defined centroid. Leveraging this, we first devise a centroid-anchored synergistic paradigm that utilizes predicted centroids as shared anchors to simultaneously condition dense segmentation and instance-level localization. To counteract the tumor size imbalance, we further devise a Volume-Calibrated Loss (VC-Loss) that adaptively amplifies the gradient contribution of micro-lesions, alongside a Size-Aware Curriculum Optimization (SACO) that stabilizes multi-task training by establishing global representations before progressively unlocking fine-grained localization. Extensive experiments demonstrate that MicroBT outperforms state-of-the-art methods, particularly on metastases, where micro-lesion ($\leq 3$ mm) localization precision improves by approximately 7% and counting estimation errors decrease by approximately 26%. The code is available at https://github.com/leonlou921/MicroBT.

0.49

CAPS: Clinically-Verifiable Anatomy-Prioritized Synthesis for Missing MRI Imputation in Brain Tumor Segmentation

eess.IV cs.CV ·2026-10-20 ·Cecilia Diana-Albelda, Arthur Longuefosse, Mario Rubén Paz Campos, Álvaro García-Martín, Jesus Bescos
similarity 0.65
Abstract · 20 pages, 6 figures, 8 tables. Cecilia Diana-Albelda and Arthur Longuefosse contributed equally

Multi-parametric MRI is the gold standard for neuro-oncology, yet acquiring complete 4-modality protocols may be unfeasible in real-world clinical practice. When handling missing modalities, existing automated systems force a critical compromise: robust segmenters operate as uninterpretable "black boxes" that bypass image generation, while standard synthesis models often produce blurry reconstructions lacking diagnostic reliability. To address this issue, we propose CAPS, a Clinically-Verifiable Anatomy-Prioritized Synthesis framework that reconciles computational precision with clinical transparency. Our multi-modal generative architecture is driven by a hybrid objective function (L_1 + L_AFP + L_DualDice) that explicitly enforces the preservation of deep anatomical features and strict topological boundaries, rather than relying solely on pixel-wise optimization. Evaluated comprehensively on the BraTS Adult Glioma dataset, the framework achieves superior synthesis fidelity across intensity-based metrics, and demonstrates robust downstream segmentation performance (82.38% mean Dice), successfully restoring verifiable visual context. Furthermore, the framework exhibits exceptional zero-shot cross-domain generalization, maintaining high structural fidelity across completely unseen Meningioma, Pediatric, and Sub-Saharan African cohorts without domain-specific adaptation. Finally, a blinded radiological assessment confirms that our anatomy-aware approach significantly enhances both perceived image quality and clinical utility, providing clinicians with the reliable visual evidence required to trust downstream automated workflows.

0.20

Pathology Randomization for Synthetic Priors and Zero-Shot Detection

cs.CV cs.AIeess.IV ·2026-11-16 ·Alexandra G. Roberts, Tonmoy Hossain, Mark Olchanyi, Stefan Brandstätter, Jonathan Williams Ramirez +5 more
benchmarkcode/data similarity 0.65
Abstract · 25 pages, 9 figures, 13 tables (8-page main text with appendices). Code: https://github.com/agr78/Pathology-Randomizer

Hospital brain imaging archives hold a diverse array of pathology at sample sizes beyond prospective studies, particularly for underrepresented populations and diseases. To unlock uncurated clinical data and scale analysis, methods are needed to detect abnormalities across contrasts and resolutions. Synthetic data has provided robust, contrast-agnostic models for a variety of human neuroimaging tasks in healthy anatomy, but pathology detection and other tasks in clinical settings still require real patient data, contrast-specific models, or disease-specific generators. We propose PathoDraw, a generative model of brain MRI with pathology. A conditional distribution of lesions given the healthy anatomy is drawn into the label map before contrast-agnostic rendering, and a single network estimates healthy anatomy with exact signed intensity deviation of any input scan. The contrast-agnostic 3D UNet learns the healthy labels under the lesion and the signed deviation directly and identifies pathology via robust tissue statistics and learned features, despite no training on real pathology. We show zero-shot detection on public stroke, tumor, and white matter hyperintensity datasets as well as archived clinical data, spanning $T_1$w, FLAIR and $T_2$w at various resolutions under a recent unsupervised anomaly detection benchmark protocol. Our single model exceeds or performs comparably to contrast-specific anomaly detectors trained on real scans and keeps healthy anatomy intact. The same generator trains networks for super-resolution and for registration in the presence of pathology. Our model, robust across acquisition and disease, enables the use of uncurated, archived data for clinical analysis. Our code is available at https://github.com/agr78/Pathology-Randomizer.

0.35

AsymFeX: A Symmetry-Driven Framework for Ischemic Stroke Segmentation Across Imaging Modalities and Stroke Stages

eess.IV cs.CV ·2026-08-20 ·Maunil Shah, Vaanathi Sundaresan
code/data similarity 0.65
Abstract

Fast and accurate segmentation of Acute Ischemic Stroke (AIS) lesions is essential for stroke prognosis and treatment planning. Non-contrast CT (NCCT), the first-line imaging modality for diagnosing ischemic infarcts, exhibits subtle infarct contrast, making manual delineation slow and labor-intensive. Motivated by this, and by the clinical practice of comparing brain hemispheres to localize infarcts, we propose a two-stage, nnU-Net-compatible 3D segmentation method. The first stage corrects head tilt to align each scan to its true anatomical mid-sagittal plane; the second applies a novel Asymmetric Feature Extraction (AsymFeX) module, comparing each voxel to its true contralateral counterpart within a local 3 x 3 x 3 neighborhood via cross-hemispheric attention, feature disparity estimation, and dual-scale gating to capture both large and small infarcts. On AISD, our method achieves 0.6796 Dice, 23.53 mm HD95, and 7.69 mL AVD, significantly outperforming existing state-of-the-art methods, with clinically relevant volumetric analysis at the 70 mL thrombolysis-eligibility threshold. Proof-of-concept evaluation on ATLAS v2.1 and ISLES'24 demonstrates that the same symmetry-driven design generalizes across imaging modalities and stroke time points without architectural changes, further supported by an uncertainty analysis assessing reliability under clinical deployment. Code is publicly available at https://github.com/biomedia-lab/AIS-detection.

0.23